0,768  0,005  Aldehyde oxidase inhibitor
0,729  0,020  Caspase 9 stimulant
0,663  0,016  GST A substrate
0,648  0,010  5 Hydroxytryptamine release stimulant
0,631  0,005  GABA C receptor rho-3 antagonist
0,640  0,014  Prostate cancer treatment
0,594  0,012  Cardiovascular analeptic
0,604  0,023  Antineoplastic (colorectal cancer)
0,597  0,022  Antineoplastic (colon cancer)
0,586  0,014  CTGF expression inhibitor
0,578  0,007  Antineoplastic enhancer
0,604  0,034  Antineoplastic (breast cancer)
0,583  0,013  5 Hydroxytryptamine release inhibitor
0,575  0,005  Carcinogenic, group 3
0,579  0,015  Antineoplastic (cervical cancer)
0,563  0,004  Antineoplastic (bladder cancer)
0,570  0,016  Antineoplastic (melanoma)
0,566  0,012  Antineoplastic (non-small cell lung cancer)
0,567  0,017  CYP1A2 substrate
0,555  0,015  UGT1A9 substrate
0,552  0,012  Antineoplastic (glioma)
0,545  0,005  Topoisomerase II inhibitor
0,553  0,014  Ulceration
0,537  0,009  Antineoplastic (glioblastoma multiforme)
0,547  0,020  Antipruritic, allergic
0,524  0,008  UGT1A4 substrate
0,522  0,011  Superoxide dismutase inhibitor
0,526  0,015  FMO1 substrate
0,512  0,007  Genotoxic
0,528  0,031  CYP2C9 substrate
0,518  0,025  CYP2C19 substrate
0,500  0,007  UGT1A3 substrate
0,513  0,024  Histamine release inhibitor
0,515  0,027  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,490  0,005  Carcinogenic, group 2B
0,489  0,004  GST M1-1 substrate
0,519  0,036  Antileukemic
0,535  0,064  Apoptosis agonist
0,485  0,022  MAP kinase kinase 6 inhibitor
0,463  0,003  Excitatory amino acid transporter EAAC1 inhibitor
0,464  0,005  NOS3 expression enhancer
0,460  0,005  Pneumotoxic
0,483  0,029  Antineoplastic (ovarian cancer)
0,463  0,016  UGT1A6 substrate
0,476  0,029  CYP2D6 substrate
0,448  0,005  Tyrosine 3 hydroxylase inhibitor
0,484  0,048  Antineoplastic (lung cancer)
0,445  0,013  Antimutagenic
0,456  0,024  Mutagenic
0,476  0,045  CYP3A4 substrate
0,435  0,009  5 Hydroxytryptamine uptake stimulant
0,443  0,021  UGT2B4 substrate
0,447  0,027  Cytostatic
0,448  0,028  Carcinogenic
0,430  0,021  Cardiodepressant
0,410  0,003  NAT1 substrate
0,423  0,018  UDP-glucuronosyltransferase substrate
0,418  0,014  Flavin-containing monooxygenase substrate
0,409  0,004  Telomerase inhibitor
0,430  0,027  NOS2 expression inhibitor
0,420  0,018  Peroxidase inhibitor
0,408  0,008  UGT2B15 substrate
0,420  0,024  DNA damaging
0,395  0,005  Topoisomerase II alpha inhibitor
0,412  0,021  Antineoplastic (renal cancer)
0,451  0,061  TNF expression inhibitor
0,392  0,017  Antineoplastic (sarcoma)
0,433  0,060  Calcium channel L-type activator
0,392  0,020  Interleukin agonist
0,374  0,003  Xanthine oxidase substrate
0,407  0,043  Teratogen
0,382  0,019  UGT1A1 substrate
0,404  0,044  Respiratory analeptic
0,393  0,033  Sensitization
0,379  0,019  Anesthetic general
0,408  0,049  Antiprotozoal (Plasmodium)
0,387  0,030  Calcium channel activator
0,396  0,041  AR expression inhibitor
0,411  0,057  CYP2C19 inhibitor
0,370  0,020  Antiparkinsonian, rigidity relieving
0,352  0,004  NAT2 substrate
0,354  0,007  GABA C receptor agonist
0,373  0,027  FMO3 substrate
0,355  0,011  Alpha-N-acetylglucosaminidase inhibitor
0,386  0,043  12-Lipoxygenase inhibitor
0,353  0,015  Antipruritic, non-allergic
0,386  0,049  Caspase 3 stimulant
0,359  0,023  Abortion inducer
0,344  0,008  Topoisomerase I inhibitor
0,362  0,028  DNA synthesis inhibitor
0,341  0,008  5-Lipoxygenase inhibitor
0,374  0,046  Embryotoxic
0,360  0,032  Amyloid beta aggregation inhibitor
0,397  0,070  Antiprotozoal
0,336  0,010  Acetylcholinesterase inhibitor
0,347  0,024  RNA-directed DNA polymerase inhibitor
0,364  0,041  Hypoxia-inducible factor 1 alpha inhibitor
0,368  0,047  Antineoplastic (brain cancer)
0,358  0,038  Radiosensitizer
0,326  0,008  Cystathionine beta-synthase inhibitor
0,325  0,010  DNA intercalator
0,364  0,050  Antihypercholesterolemic
0,327  0,014  GST P1-1 substrate
0,328  0,015  Acaricide
0,333  0,020  UGT2B7 substrate
0,361  0,050  Vasodilator, coronary
0,315  0,005  Arylamine N-Acetyltransferase substrate
0,359  0,049  Antineoplastic (pancreatic cancer)
0,315  0,010  Sulfotransferase substrate
0,319  0,016  Cholinergic
0,311  0,009  Carcinogenic, group 1
0,304  0,004  Creatine kinase inhibitor
0,304  0,005  GABA C receptor rho-2 antagonist
0,336  0,037  Acute neurologic disorders treatment
0,308  0,011  Platelet activating factor beta antagonist
0,302  0,005  Phobic disorders treatment
0,363  0,068  Vasodilator, peripheral
0,325  0,030  Platelet aggregation inhibitor
0,336  0,045  Antipyretic
0,295  0,005  SULT1A1 substrate
0,329  0,042  Transcription factor STAT inhibitor
0,328  0,041  Transcription factor STAT3 inhibitor
0,334  0,047  CYP1A2 inhibitor
0,332  0,046  Antineoplastic (small cell lung cancer)
0,339  0,054  Lipoxygenase inhibitor
0,311  0,027  Dual specificity phosphatase inhibitor
0,338  0,056  Analeptic
0,286  0,004  MAP3K9 inhibitor
0,309  0,027  Eye irritation, high
0,290  0,009  MAP kinase kinase 3 inhibitor
0,290  0,012  UGT2B9 substrate
0,301  0,023  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,284  0,007  Mannose-6-phosphate isomerase inhibitor
0,332  0,055  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,335  0,059  NOS3 expression inhibitor
0,303  0,028  5 Hydroxytryptamine 1E antagonist
0,319  0,045  Antineoplastic (lymphoma)
0,351  0,080  CYP2C9 inhibitor
0,282  0,011  SULT1A3 substrate
0,339  0,069  Cholesterol antagonist
0,301  0,031  Muscle relaxant
0,288  0,019  Phospholipase C inhibitor
0,275  0,007  VEGF expression inhibitor
0,274  0,008  UGT2B10 substrate
0,317  0,052  Antihypoxic
0,325  0,061  Spasmolytic
0,316  0,053  Chemoprotective
0,356  0,096  15-Lipoxygenase inhibitor
0,276  0,015  Succinate dehydrogenase inhibitor
0,284  0,024  Skeletal muscle relaxant
0,275  0,016  Adenylate cyclase inhibitor
0,276  0,018  MAO A inhibitor
0,273  0,016  Glutathione S-transferase substrate
0,276  0,020  CNS active muscle relaxant
0,293  0,038  Gastrin inhibitor
0,269  0,014  Hexokinase inhibitor
0,279  0,025  Lipocortins synthesis antagonist
0,278  0,025  Neurotrophic factor enhancer
0,300  0,048  Pyruvate kinase inhibitor
0,302  0,051  Cytotoxic
0,266  0,016  Aldehyde dehydrogenase inhibitor
0,262  0,013  Butyrylcholinesterase inhibitor
0,256  0,009  Carbonic anhydrase III inhibitor
0,268  0,021  Antiviral (West Nile virus)
0,283  0,037  Antihypotensive
0,327  0,084  Transcription factor NF kappa B inhibitor
0,247  0,005  Carcinogenic, group 2A
0,275  0,034  Non-steroidal antiinflammatory agent
0,246  0,005  Alcohol oxidase inhibitor
0,253  0,015  5 Hydroxytryptamine 3E antagonist
0,245  0,009  Antirickettsial
0,283  0,049  Cyclic AMP phosphodiesterase inhibitor
0,344  0,109  Antiparkinsonian
0,241  0,007  GABA C receptor antagonist
0,248  0,013  UDP-glucose 4-epimerase inhibitor
0,237  0,005  GABA C receptor rho-1 antagonist
0,239  0,008  Antiprotozoal (Babesia)
0,277  0,046  Chemopreventive
0,238  0,008  Porphobilinogen synthase inhibitor
0,290  0,061  Antiprotozoal (Trypanosoma)
0,242  0,014  Ferrochelatase inhibitor
0,298  0,072  Cardioprotectant
0,335  0,111  Antibacterial
0,293  0,070  Radioprotector
0,230  0,007  NAD(P)H dehydrogenase (quinone) inhibitor
0,233  0,010  Arachidonic acid antagonist
0,250  0,028  MAO inhibitor
0,226  0,004  GST T1-1 substrate
0,281  0,060  Antineoplastic (liver cancer)
0,251  0,030  Contraceptive
0,250  0,029  Antiseptic
0,230  0,010  Antineoplastic, alkylator
0,240  0,023  Toll-Like receptor 9 antagonist
0,247  0,029  Amylase inhibitor
0,226  0,009  5 Hydroxytryptamine 3A agonist
0,262  0,045  Sedative
0,256  0,041  Antialcoholic
0,243  0,029  Antiparkinsonian, tremor relieving
0,222  0,009  Antihelmintic (Trematoda)
0,217  0,005  DOPA decarboxylase inhibitor
0,217  0,004  Antidote, mercury
0,223  0,011  Histidine decarboxylase inhibitor
0,217  0,007  Keratolytic
0,234  0,024  Antidiarrheal
0,298  0,089  Antithrombotic
0,240  0,032  Diuretic
0,243  0,037  Nitric-oxide synthase stimulant
0,216  0,012  Coagulant
0,280  0,078  Antineoplastic (multiple myeloma)
0,207  0,007  Postmenopausal disorders treatment
0,207  0,007  Beta tubulin antagonist
0,203  0,003  Ca2+-transporting ATPase inhibitor
0,227  0,028  Aldehyde oxidase substrate
0,219  0,021  Alkylator
0,227  0,030  Tubulin antagonist
0,255  0,058  Antiparasitic
0,201  0,005  Dopamine D5 antagonist
0,238  0,043  CYP2B6 inhibitor
0,262  0,068  Proliferative diseases treatment
0,218  0,025  Aldose reductase substrate
0,204  0,010  Triose-phosphate isomerase inhibitor
0,205  0,011  Antihelmintic (Fasciola)
0,208  0,017  Antiprotozoal (Amoeba)
0,250  0,059  Psychostimulant
0,202  0,013  Hearing loss treatment
0,269  0,080  Insulysin inhibitor
0,206  0,018  CF transmembrane conductance regulator agonist
0,261  0,074  Aryl hydrocarbon receptor agonist
0,199  0,013  Carbonic anhydrase VI inhibitor
0,281  0,097  Sodium/bile acid cotransporter inhibitor
0,251  0,067  Antineoplastic (lymphocytic leukemia)
0,188  0,005  GABA aminotransferase inhibitor
0,198  0,014  Adenylate cyclase stimulant
0,212  0,029  ATPase inhibitor
0,201  0,018  Antischistosomal
0,217  0,035  Melanin inhibitor
0,187  0,005  Antifungal (Pneumocystis)
0,200  0,019  Cyclooxygenase 3 inhibitor
0,194  0,013  HIV-1 integrase (Overall Integration) inhibitor
0,211  0,031  Uterine stimulant
0,185  0,005  Acetylcholine release stimulant
0,216  0,036  Protein kinase stimulant
0,194  0,015  Contraceptive female
0,208  0,029  Antiprotozoal (Coccidial)
0,200  0,022  Antihemorrhagic
0,219  0,042  3C-like protease (Human coronavirus) inhibitor
0,215  0,038  Prostate disorders treatment
0,188  0,013  Antineoplastic (uterine cancer)
0,266  0,092  CYP2D6 inhibitor
0,189  0,015  Antispirochetal
0,184  0,012  DNA repair enzyme inhibitor
0,187  0,016  Photosensitizer
0,224  0,053  I kappa B kinase epsilon inhibitor
0,175  0,004  Topoisomerase II beta inhibitor
0,212  0,042  Heat shock protein 90 alpha antagonist
0,187  0,018  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,270  0,102  Bone diseases treatment
0,211  0,044  Antiviral (Ebola)
0,223  0,057  Antihelmintic
0,198  0,032  Antifungal enhancer
0,204  0,039  Interferon gamma antagonist
0,220  0,056  Sigma receptor agonist
0,180  0,016  TRPA1 agonist
0,241  0,078  Antiprotozoal (Leishmania)
0,211  0,047  Antianorexic
0,181  0,019  UGT2B1 substrate
0,178  0,019  Potassium channel (Ca-activated) activator
0,168  0,010  Glutamate decarboxylase inhibitor
0,167  0,009  UGT2B11 substrate
0,187  0,030  Platelet activating factor antagonist
0,172  0,015  Prolactin inhibitor
0,174  0,017  Antiviral (Influenza B)
0,182  0,027  Nav1.6 sodium channel blocker
0,162  0,008  TRPA1 antagonist
0,170  0,018  Estrogen antagonist
0,164  0,012  Anabolic
0,184  0,035  Psychosexual dysfunction treatment
0,170  0,021  Mediator release inhibitor
0,195  0,046  Toxic, respiratory center
0,174  0,026  Interleukin 1b antagonist
0,161  0,014  Estrogen receptor beta antagonist
0,277  0,130  Calpain 2 inhibitor
0,160  0,013  SULT1E1 substrate
0,216  0,071  VCAM1 expression inhibitor
0,183  0,038  Skin irritative effect
0,188  0,044  Anesthetic
0,235  0,092  Antioxidant
0,159  0,017  Electron transport complex I inhibitor
0,198  0,057  LDLR expression enhancer
0,169  0,029  Microtubule formation inhibitor
0,161  0,023  Adenylate kinase inhibitor
0,172  0,035  Cholesterol synthesis inhibitor
0,225  0,089  Calpain inhibitor
0,157  0,022  Sphingomyelinase inhibitor
0,202  0,067  Focal adhesion kinase 2 inhibitor
0,150  0,016  CYP2A6 inhibitor
0,143  0,009  Glycine receptor antagonist
0,141  0,008  CDC25B inhibitor
0,181  0,048  Heat shock protein 90 antagonist
0,265  0,132  Stroke treatment
0,138  0,008  Granulocyte macrophage colony stimulating factor agonist
0,156  0,026  Antiviral (Papilloma)
0,142  0,012  Glutamate release inhibitor
0,175  0,046  Raynaud's phenomenon treatment
0,157  0,028  Carbonic anhydrase XV inhibitor
0,147  0,018  NADH dehydrogenase inhibitor
0,158  0,030  Heat shock protein 70 antagonist
0,165  0,037  Cathepsin H inhibitor
0,218  0,091  Neuropeptide Y2 antagonist
0,130  0,003  Dopamine D5 agonist
0,165  0,039  MAP kinase kinase 4 inhibitor
0,198  0,072  Histone acetyltransferase inhibitor
0,199  0,074  Insulin sensitizer
0,159  0,034  MAO B inhibitor
0,149  0,024  Breast cancer-resistant protein inhibitor
0,138  0,014  Estrogen receptor alpha antagonist
0,128  0,004  Antidote, organophosphates
0,137  0,015  Aromatase inhibitor
0,131  0,009  Narcotic antagonist
0,245  0,123  Antineoplastic (osteosarcoma)
0,185  0,064  Mcl-1 antagonist
0,166  0,044  Movement disorders treatment
0,180  0,059  Muscular dystrophy treatment
0,138  0,017  Glutamate (mGluR7) agonist
0,183  0,062  Antipruritic
0,125  0,007  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,151  0,033  Papain-like protease (SARS coronavirus) inhibitor
0,150  0,033  Sphingosine 1-phosphate receptor 4 antagonist
0,123  0,005  Aconitate hydratase inhibitor
0,185  0,068  Male reproductive disfunction treatment
0,138  0,021  Phosphofructokinase-1 inhibitor
0,224  0,107  Immunostimulant
0,138  0,023  Protein kinase C zeta inhibitor
0,129  0,014  Interferon agonist
0,145  0,032  Antineoplastic antibiotic
0,138  0,025  Electrolyte absorption antagonist
0,163  0,050  Cyclooxygenase 1 inhibitor
0,129  0,018  Bromodomain-containing protein 2 inhibitor
0,168  0,057  Lipid peroxidase inhibitor
0,156  0,045  Antihyperlipoproteinemic
0,118  0,007  Aldosterone antagonist
0,141  0,031  Transcription factor STAT6 inhibitor
0,125  0,014  Argininosuccinate synthase inhibitor
0,130  0,020  Glutamate dehydrogenase inhibitor
0,127  0,017  CDC25A inhibitor
0,113  0,004  Adenylate cyclase 1 inhibitor
0,155  0,046  Antiprotozoal (Trichomonas)
0,126  0,018  Antiprotozoal activity enhancer
0,154  0,046  Pregnane X receptor agonist
0,205  0,097  Antiamyloidogenic
0,112  0,005  SULT2A1 substrate
0,157  0,050  NADPH oxidase inhibitor
0,146  0,038  Antiviral (Poxvirus)
0,159  0,052  Interleukin 1 antagonist
0,110  0,004  Retinoid X alpha receptor agonist
0,112  0,006  Potassium channel intermediate-conductance Ca-activated blocker
0,155  0,049  Toll-Like receptor 2 antagonist
0,129  0,024  Histamine N-methyltransferase inhibitor
0,181  0,076  Nitric oxide antagonist
0,235  0,131  CYP3A4 inhibitor
0,168  0,064  Protein-tyrosine phosphatase inhibitor
0,146  0,042  Gastritis treatment
0,116  0,012  Purinergic P2X1 antagonist
0,109  0,005  Antihemophilic
0,145  0,041  Alpha 2b adrenoreceptor antagonist
0,128  0,024  Tourette's syndrome treatment
0,140  0,036  Caspase 3 inhibitor
0,117  0,014  Estrogen agonist
0,112  0,009  Phospholipase D inhibitor
0,153  0,051  Cocaine dependence treatment
0,115  0,012  Sleep apnea treatment
0,128  0,026  Paget's disease treatment
0,154  0,053  Toll-Like receptor antagonist
0,155  0,054  Sphingosine 1-phosphate receptor 5 antagonist
0,107  0,007  Glutamate (mGluR7) antagonist
0,139  0,039  Protein kinase C gamma inhibitor
0,167  0,068  Neurotensin receptor agonist
0,107  0,008  Glutamate (mGluR6) antagonist
0,160  0,062  Antineoplastic (carcinoma)
0,120  0,023  Antileprosy
0,103  0,008  Exportin-1 inhibitor
0,110  0,015  Acetylcholine M5 receptor agonist
0,106  0,011  Estrogen receptor beta agonist
0,113  0,018  Caspase 7 inhibitor
0,129  0,035  Antiprotozoal (Toxoplasma)
0,195  0,102  Free radical scavenger
0,137  0,044  Aminopeptidase B inhibitor
0,117  0,025  Tocolytic
0,108  0,017  Estrogen-related receptor beta agonist
0,108  0,017  Glycine receptor agonist
0,155  0,064  Thiol protease inhibitor
0,125  0,035  Mental retardation treatment
0,109  0,019  T cell inhibitor
0,102  0,012  MAP kinase kinase 7 inhibitor
0,093  0,004  ATM kinase inhibitor
0,103  0,014  Dopamine D4 agonist
0,152  0,063  Cell wall synthesis inhibitor
0,152  0,064  Antineoplastic (squamous cell carcinoma)
0,109  0,022  Phenylalanine 4-hydroxylase inhibitor
0,117  0,030  Antiviral (Rhinovirus)
0,133  0,046  GABA receptor agonist
0,129  0,042  AMP-activated protein kinase stimulant
0,093  0,007  Anesthetic inhalation
0,135  0,048  5 Hydroxytryptamine 2B antagonist
0,105  0,019  Carbamoyl phosphate synthetase inhibitor
0,095  0,010  CD45 antagonist
0,122  0,036  Nitric-oxide synthase inhibitor
0,094  0,009  Corticotropin releasing factor 2 receptor antagonist
0,129  0,044  Alpha 2c adrenoreceptor antagonist
0,098  0,013  Antimycoplasmal
0,147  0,062  Bone formation stimulant
0,130  0,046  Mucolytic
0,117  0,034  Catalase inhibitor
0,090  0,007  Dihydroorotate oxidase inhibitor
0,111  0,029  Inducible nitric-oxide synthase inhibitor
0,128  0,046  Expectorant
0,115  0,033  ALK inhibitor
0,130  0,048  Endometrios treatment
0,111  0,029  Cathepsin G inhibitor
0,118  0,036  Alcohol dehydrogenase inhibitor
0,087  0,006  Retinoid X receptor agonist
0,170  0,090  P-glycoprotein inhibitor
0,176  0,096  DNA methylase inhibitor
0,142  0,062  Nav1.2 sodium channel blocker
0,089  0,009  Calcium channel P-type blocker
0,092  0,012  Potassium channel (Ca-activated) blocker
0,091  0,012  Estradiol 17 beta-dehydrogenase inhibitor
0,137  0,058  Antibacterial (Helicobacter pylori)
0,151  0,072  Antidote
0,222  0,143  Prostaglandin dehydrogenase inhibitor
0,083  0,005  Pregnane X receptor antagonist
0,136  0,059  Antismoking
0,087  0,010  Postcoital contraceptive
0,131  0,055  Monophenol monooxygenase inhibitor
0,086  0,011  Estrogen receptor alpha agonist
0,095  0,020  Biliverdin reductase inhibitor
0,201  0,126  Antiosteoporotic
0,102  0,027  Aminopeptidase I inhibitor
0,099  0,023  CC chemokine 5 receptor agonist
0,095  0,020  GABA B receptor agonist
0,079  0,004  Delayed rectifier potassium channel blocker
0,095  0,021  Vanilloid 4 agonist
0,134  0,059  Vanilloid 1 agonist
0,147  0,073  MAP kinase 3 inhibitor
0,163  0,088  Antineoplastic (gastric cancer)
0,114  0,040  Interleukin 1 beta converting enzyme inhibitor
0,113  0,039  Calcium antagonist
0,092  0,019  Protease 3C (Human rhinovirus) inhibitor
0,090  0,016  Antiviral (Parainfluenza)
0,155  0,081  Antihelmintic (Nematodes)
0,136  0,063  Sphingosine 1-phosphate receptor 2 antagonist
0,092  0,020  S-adenosyl-L-methionine decarboxylase inhibitor
0,091  0,019  5 Hydroxytryptamine 2A agonist
0,118  0,047  Urease inhibitor
0,111  0,040  NMDA receptor antagonist
0,107  0,036  Restless leg syndrome treatment
0,186  0,116  Vasodilator
0,080  0,011  DNA helicase inhibitor
0,095  0,026  Potassium channel large-conductance Ca-activated activator
0,099  0,031  D-Ala-D-Ala ligase inhibitor
0,090  0,022  NMDA receptor glycine site agonist
0,144  0,076  Hemostatic
0,079  0,012  Bcl-xL inhibitor
0,085  0,018  Alpha tubulin antagonist
0,085  0,018  Heat shock protein 90 beta antagonist
0,145  0,079  Acetylcholine M1 receptor antagonist
0,099  0,032  Nicotinic alpha4beta2 receptor antagonist
0,127  0,060  Beta amyloid protein antagonist
0,138  0,072  Cytokine production inhibitor
0,070  0,004  ATP citrate lysase inhibitor
0,102  0,036  GABA A receptor agonist
0,084  0,019  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,069  0,005  Phenylethanolamine N methyltransferase inhibitor
0,076  0,011  Progesterone antagonist
0,085  0,021  Androgen agonist
0,114  0,050  Xanthine oxidase inhibitor
0,086  0,022  5 Hydroxytryptamine 3 agonist
0,094  0,030  Dopamine agonist
0,160  0,096  Antineoplastic (bone cancer)
0,091  0,028  Dopamine D1 antagonist
0,074  0,011  Glucose-6-phosphate isomerase inhibitor
0,128  0,066  Nav1.3 sodium channel blocker
0,172  0,110  Dependence treatment
0,107  0,045  Lanosterol 14 alpha demethylase inhibitor
0,075  0,013  Potassium channel Kv1.3 blocker
0,275  0,213  Antineoplastic (solid tumors)
0,101  0,040  Interleukin 5 antagonist
0,067  0,006  Guanylate cyclase inhibitor
0,067  0,005  Sodium-dependent vitamin C transporter 2 inhibitor
0,110  0,049  Antifungal (Aspergillus)
0,112  0,050  Chronic obstructive bronchitis treatment
0,155  0,094  Tumour necrosis factor antagonist
0,075  0,014  Glutamate (mGluR group I) agonist
0,068  0,008  Alpha 1d adrenoreceptor agonist
0,152  0,092  Cyclin-dependent kinase 3 inhibitor
0,096  0,036  Na+ K+ transporting ATPase inhibitor
0,092  0,032  Check point kinase 1 inhibitor
0,096  0,037  mTOR complex 2 inhibitor
0,078  0,019  Transcription factor RelA inhibitor
0,078  0,020  Fatty acid synthase inhibitor
0,112  0,054  Nav1.1 sodium channel blocker
0,120  0,063  Menstruation disorders treatment
0,074  0,017  5 Hydroxytryptamine 2 agonist
0,100  0,044  Ornithine decarboxylase inhibitor
0,079  0,023  Acyl-CoA dehydrogenase inhibitor
0,155  0,099  DNA methyltransferase I inhibitor
0,158  0,104  Antiviral (Hepatitis)
0,134  0,080  Hair growth stimulant
0,096  0,042  Antiviral (Hepatitis A)
0,081  0,028  Protein kinase C beta inhibitor
0,075  0,022  Cyclin D1 inhibitor
0,078  0,025  Beta 3 adrenoreceptor antagonist
0,064  0,012  Purinergic P2X4 antagonist
0,057  0,005  Vanilloid 3 antagonist
0,094  0,041  Carbonic anhydrase XIII inhibitor
0,063  0,011  GABA B receptor antagonist
0,100  0,047  Antithrombocytopenic
0,118  0,066  Antitussive
0,078  0,025  Alpha 2 adrenoreceptor agonist
0,070  0,018  Nicotinic alpha3beta2 receptor antagonist
0,135  0,083  Cyclooxygenase inhibitor
0,146  0,095  Antiviral (Hepatitis C)
0,092  0,040  Macrophage migration inhibitory factor inhibitor
0,099  0,047  Actinic keratosis treatment
0,070  0,019  5 Hydroxytryptamine 7 agonist
0,057  0,006  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,060  0,009  Nerve growth factor antagonist
0,113  0,063  Myasthenia Gravis treatment
0,094  0,045  Antiviral (Trachoma)
0,063  0,015  Cholesterol esterase inhibitor
0,058  0,011  GABA uptake inhibitor
0,126  0,079  Alkaline phosphatase inhibitor
0,147  0,100  LIM domain kinase 1 inhibitor
0,077  0,030  NMDA receptor agonist
0,100  0,053  Phosphodiesterase 6D inhibitor
0,116  0,069  Proteasome inhibitor
0,055  0,009  Retinoid X receptor antagonist
0,098  0,051  Thioredoxin inhibitor
0,067  0,021  Ryanodine receptor antagonist
0,060  0,014  Glutamate (mGluR4) antagonist
0,075  0,029  Interferon inducer
0,139  0,094  Neuropathy treatment
0,115  0,069  Shock treatment
0,059  0,014  Glutamate (mGluR group III) antagonist
0,094  0,049  5 Hydroxytryptamine 2C antagonist
0,054  0,010  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,085  0,041  Acetylcholine M4 receptor antagonist
0,122  0,078  Cyclooxygenase 2 inhibitor
0,088  0,044  Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor
0,114  0,070  Interleukin 8 antagonist
0,058  0,015  Geranyltranstransferase inhibitor
0,062  0,020  Immunoglobulin Fc receptor antagonist
0,073  0,030  NMDA 2C receptor antagonist
0,093  0,052  Androgen antagonist
0,088  0,047  Acetylcholine nicotinic antagonist
0,141  0,100  Cystic fibrosis treatment
0,049  0,008  Melatonin receptor 1A agonist
0,048  0,007  Retinoid X alpha receptor antagonist
0,054  0,013  Histamine H1 receptor agonist
0,173  0,132  Tumour necrosis factor alpha release inhibitor
0,120  0,080  Retinoprotector
0,070  0,030  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,052  0,012  Potassium channel Kv1.1 blocker
0,085  0,045  Alpha 2a adrenoreceptor antagonist
0,051  0,011  Glutamate (mGluR8) agonist
0,071  0,032  Narcolepsy treatment
0,094  0,055  Potassium channel activator
0,052  0,013  Retinoic acid alpha receptor agonist
0,077  0,039  Neuronal nicotinic receptor antagonist
0,112  0,073  Anesthetic local
0,151  0,113  Antimigraine
0,068  0,029  Carbonic anhydrase VB inhibitor
0,043  0,005  Glutamate (mGluR1) agonist
0,103  0,065  Beta glucuronidase inhibitor
0,092  0,054  Alpha 2 adrenoreceptor antagonist
0,051  0,013  Kainate receptor agonist
0,191  0,154  Antidepressant
0,056  0,020  Dopamine beta hydroxylase inhibitor
0,104  0,067  Falcipain 3 inhibitor
0,060  0,023  Lysophosphatidic acid 3 receptor antagonist
0,104  0,068  5 Hydroxytryptamine 2 antagonist
0,050  0,014  Heme oxygenase inhibitor
0,044  0,008  Nicotinic alpha3beta4 receptor agonist
0,055  0,020  Dihydroorotase inhibitor
0,049  0,014  Antihyperaldosteronism
0,050  0,015  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,058  0,023  Potassium channel (Inward rectifier) activator
0,087  0,052  I kappa B kinase inhibitor
0,125  0,091  CC chemokine 6 receptor antagonist
0,104  0,069  Choleretic
0,071  0,037  Uterine relaxant
0,076  0,044  Potassium channel (Tandem pore domain) blocker
0,139  0,106  Dual specificity phosphatase 3 inhibitor
0,055  0,022  Potassium channel (ATP-sensitive) activator
0,045  0,013  Purinergic P2Y2 antagonist
0,073  0,042  Anticholelithogenic
0,104  0,072  Multidrug resistance-associated protein 1 inhibitor
0,084  0,052  Acetylcholine nicotinic agonist
0,074  0,043  Bulimia treatment
0,130  0,099  Neuropeptide Y1 antagonist
0,043  0,012  Nucleoside transporters inhibitor
0,053  0,022  Cytokine production stimulant
0,067  0,037  I kappa B kinase 2 inhibitor
0,076  0,046  NMDA 2 receptor antagonist
0,083  0,053  Thioredoxin reductase inhibitor
0,057  0,027  Prolyl endopeptidase inhibitor
0,076  0,047  Phosphodiesterase VI inhibitor
0,130  0,101  Phospholipase A2 inhibitor
0,034  0,005  Imidazoline I1 receptor antagonist
0,051  0,023  Potassium channel small-conductance Ca-activated blocker
0,045  0,017  5 Hydroxytryptamine 2B agonist
0,031  0,003  Antibiotic Anthracycline-like
0,072  0,044  Carbonic anhydrase VA inhibitor
0,035  0,008  Nicotinic acid receptor 2 antagonist
0,044  0,016  Fumarate hydratase inhibitor
0,065  0,037  5 Hydroxytryptamine 5A antagonist
0,070  0,043  Gaucher disease treatment
0,031  0,004  Vesicular glutamate transport inhibitor
0,117  0,090  Skin whitener
0,068  0,041  Beta adrenoreceptor antagonist
0,083  0,057  MAP-kinase-activated kinase inhibitor
0,047  0,021  Thymidine kinase inhibitor
0,068  0,043  MDM2 inhibitor
0,126  0,100  Antianemic
0,067  0,041  HIV-1 integrase (3'-Processing) inhibitor
0,092  0,067  Bile acid receptor antagonist
0,033  0,008  Glutamate (mGluR1a) agonist
0,050  0,025  Glutamate (mGluR5) agonist
0,043  0,018  5 Hydroxytryptamine 3B antagonist
0,033  0,008  Hedgehog signaling activator
0,116  0,091  Erectile dysfunction treatment
0,053  0,029  Squalene epoxidase inhibitor
0,049  0,024  Leukocyte elastase inhibitor
0,028  0,005  Retinoid X beta receptor antagonist
0,066  0,043  Aryl hydrocarbon receptor antagonist
0,031  0,009  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,055  0,033  NMDA 2A receptor antagonist
0,071  0,049  Benzodiazepine agonist
0,077  0,055  Glutamate receptor agonist
0,064  0,042  Dopamine D3 antagonist
0,043  0,021  MAP3K5 inhibitor
0,082  0,061  Histamine H2 receptor antagonist
0,031  0,010  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,043  0,022  5-Alpha-reductase inhibitor
0,027  0,005  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,177  0,157  Antineurogenic pain
0,030  0,010  Vanilloid 2 agonist
0,043  0,023  Membrane dipeptidase inhibitor
0,055  0,035  Alpha-mannosidase inhibitor
0,023  0,003  Antibiotic Tetracycline-like
0,026  0,007  Excitatory amino acid transporter 3 inhibitor
0,024  0,005  Excitatory amino acid transporter 1 inhibitor
0,149  0,130  Anticonvulsant
0,033  0,014  Nicotinic alpha4beta2 receptor agonist
0,104  0,086  Antineoplastic antimetabolite
0,044  0,025  Glutamate (mGluR1a) antagonist
0,079  0,060  5 Hydroxytryptamine 2A antagonist
0,048  0,030  Antiviral (Enterovirus)
0,040  0,021  Glutamate (mGluR3) antagonist
0,056  0,038  Leukotriene C antagonist
0,054  0,036  Nicotinic receptor alpha7 subunit antagonist
0,063  0,046  Hyperparathyroidism treatment
0,060  0,043  Antidote, heavy metal
0,037  0,019  Free fatty acid receptor 1 antagonist
0,055  0,038  Acetylcholine muscarinic agonist
0,071  0,053  Orexin receptor 1 antagonist
0,058  0,040  5 Hydroxytryptamine 5 antagonist
0,030  0,013  Glucosylceramidase stimulant
0,066  0,049  Alpha adrenoreceptor agonist
0,027  0,010  GRP78 expression inhibitor
0,035  0,019  Protein kinase (CK2) beta inhibitor
0,057  0,040  Xanthine dehydrogenase inhibitor
0,081  0,065  Acetylcholine agonist
0,071  0,055  Antibiotic
0,064  0,048  Carbonic anhydrase V inhibitor
0,044  0,028  Histamine H2 receptor agonist
0,060  0,045  Heme oxygenase stimulant
0,020  0,005  Thromboxane A2 agonist
0,181  0,166  Antifungal
0,022  0,008  Alpha 2b adrenoreceptor agonist
0,021  0,006  NMDA receptor phencyclidine site antagonist
0,059  0,044  Acetylcholine M5 receptor antagonist
0,071  0,056  MAP-kinase-activated kinase 2 inhibitor
0,051  0,036  Dihydroorotate dehydrogenase inhibitor
0,033  0,019  Glutamate (mGluR3) agonist
0,054  0,040  Epithelial sodium channel blocker
0,040  0,026  Urate transporter 1 inhibitor
0,044  0,030  NMDA receptor subunit 3B antagonist
0,022  0,008  Alpha 2a adrenoreceptor agonist
0,035  0,021  Sirtuin 2 inhibitor
0,137  0,124  Hepatoprotectant
0,042  0,029  DNA gyrase subunit A inhibitor
0,038  0,024  Integrin alpha2 antagonist
0,041  0,028  Cathepsin L2 inhibitor
0,067  0,054  Secretase beta inhibitor
0,027  0,014  Complement factor 1s inhibitor
0,080  0,067  Myeloperoxidase inhibitor
0,022  0,010  Antibiotic Quinolone-like
0,017  0,004  Melatonin 2 antagonist
0,144  0,132  Death-associated protein kinase 3 inhibitor
0,058  0,047  5 Hydroxytryptamine 7 antagonist
0,021  0,009  Alpha 2c adrenoreceptor agonist
0,044  0,032  Poly(ADP-ribose) polymerase inhibitor
0,036  0,025  Inosine monophosphate dehydrogenase inhibitor
0,046  0,035  Benzodiazepine antagonist
0,083  0,072  ATPase (Vacuolar H+) inhibitor
0,048  0,037  Antiviral (Herpesvirus 3, Human)
0,064  0,054  Endocannabinoid uptake inhibitor
0,029  0,019  Purinergic P2Y15 antagonist
0,022  0,012  Vesicular acetylcholine transporter inhibitor
0,029  0,019  Uridine phosphorylase inhibitor
0,024  0,014  Prostaglandin F2 alpha agonist
0,014  0,005  Imidazoline I2 receptor antagonist
0,050  0,040  Ornithine carbamoyltransferase inhibitor
0,041  0,032  Acetylcholine M1 receptor agonist
0,019  0,009  Telomerase stimulant
0,075  0,066  Opioid kappa receptor antagonist
0,035  0,026  Arginase inhibitor
0,056  0,047  Sphingosine kinase inhibitor
0,019  0,010  Nicotinic acid receptor 1 antagonist
0,044  0,036  Thymidylate synthase inhibitor
0,053  0,045  5 Hydroxytryptamine 3 antagonist
0,050  0,042  Nicotinic alpha7 receptor agonist
0,028  0,020  Estrogen-related receptor gamma antagonist
0,066  0,058  Dopamine antagonist
0,025  0,018  Acid ceramidase inhibitor
0,024  0,017  Excitatory amino acid transporter 2 inhibitor
0,076  0,068  Glutathione S-transferase inhibitor
0,067  0,060  Peroxisome proliferator-activated receptor gamma antagonist
0,057  0,050  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,036  0,029  NMDA receptor subunit 3A antagonist
0,024  0,017  Protein 30S ribosomal subunit inhibitor
0,047  0,041  Beta 2 adrenoreceptor antagonist
0,051  0,045  Sphingosine kinase 2 inhibitor
0,034  0,028  Histone deacetylase 7 inhibitor
0,085  0,079  MAP kinase kinase 1 inhibitor
0,034  0,028  Ceramide glucosyltransferase inhibitor
0,022  0,017  Dopamine D1 agonist
0,038  0,033  Liver X receptor alpha agonist
0,050  0,045  Leukotriene B4 antagonist
0,019  0,014  5-Alpha-reductase 2 inhibitor
0,022  0,017  CYP24 inhibitor
0,042  0,037  Mannosidase inhibitor
0,085  0,080  Posttraumatic stress disorder treatment
0,024  0,019  Lysophosphatidic acid receptor 1 agonist
0,030  0,025  Cholesterol ester transfer protein antagonist
0,033  0,028  Nicotinic acid receptor agonist
0,025  0,020  Integrin alpha2beta1 antagonist
0,027  0,023  5 Hydroxytryptamine 6 agonist
0,044  0,040  Carbonic anhydrase XIV inhibitor
0,064  0,059  HIV-1 integrase inhibitor
0,113  0,108  Neurotrophic factor
0,029  0,024  Prostaglandin agonist
0,043  0,039  Sigma receptor antagonist
0,058  0,054  5 Hydroxytryptamine 1B antagonist
0,020  0,017  Estrone sulfatase inhibitor
0,025  0,022  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,023  0,020  Methionyl aminopeptidase 2 inhibitor
0,013  0,010  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,008  0,005  DNA topoisomerase III inhibitor
0,013  0,010  Melatonin receptor 1A antagonist
0,021  0,018  Protease (Human cytomegalovirus) inhibitor
0,051  0,049  Alpha 1 adrenoreceptor agonist
0,172  0,170  Antiepileptic
0,051  0,049  HIV-1 integrase (Strand Transfer) inhibitor
0,067  0,065  Cushing's syndrome treatment
0,035  0,033  Dopamine D3 agonist
0,012  0,011  Human herpes virus 5 capsid protein P40 inhibitor
0,009  0,008  Progesterone receptor A antagonist
0,031  0,030  Kainate receptor 2 antagonist
0,035  0,034  Antiviral (Bovine viral diarrhea virus)
0,048  0,047  Nicotinic neuronal receptor agonist
0,038  0,037  Angiotensin AT1 receptor antagonist
0,058  0,057  Sphingosine 1-phosphate receptor 4 agonist
0,024  0,023  Sodium/glucose cotransporter 2 inhibitor
0,019  0,019  GABA transporter inhibitor
0,015  0,014  Nicotinic alpha4 receptor agonist
0,050  0,049  Dopamine D4 antagonist
0,042  0,042  Cannabinoid CB2 receptor antagonist
0,036  0,035  AMPA 4 receptor antagonist
0,082  0,082  Anticataract
0,029  0,029  GABA transporter 3 inhibitor
0,025  0,025  Baculoviral IAP repeat-containing protein 4 inhibitor
0,054  0,054  Dopamine D2 antagonist

